Thursday, October 15, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 26, 2026

GasBuddy flags worrisome gas price trend, sends message on what's next

View original at finance.yahoo.com
GasBuddy flags worrisome gas price trend, sends message on what's next The Israel-U.S. war with Iran is proving to be frustrating. Not just for the combatants or the politicians…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Trump did not know who was really in charge in Iran

    60% confidence

  • Gas prices in California, the highest-priced state, are nearing $6 on average and rising

    60% confidence

  • He doesn't see any big price breaks soon. The will to talk just doesn't seem to be there.

    60% confidence

  • The cheapest gas in the United States is in Oklahoma, with a statewide average of $3.47

    60% confidence

  • Prices typically rise in the spring and early summer as U.S. refiners build supply and change their recipes to make gasoline more environmentally friendly

    60% confidence

  • Crude oil shortages are growing in gasoline, jet fuel and related products due to insufficient supply

    60% confidence

  • U.S. gas prices jumped from $2.972/gallon on Feb. 28 to $4.167/gallon on April 8, a gain of nearly 40% and an 83% jump for the year

    60% confidence

  • Travel time to Islamabad for the negotiation meeting was too great

    60% confidence

Data points we hold from this source

United States Government · avg gas price per gallon4.07 USD
United States Government · avg gas price per gallon2.972 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com
GasBuddy flags worrisome gas price trend, sends message on what's next — Source | Via News | Finance Via News